COMMENT ON TANG ET AL. Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: A randomized trial. Diabetes care 2015;38:1339-1346

Diabetes Care

Volumn 38, Issue 9, 2015, Pages e148-e149

  Shan, Peng Fei ^a   Ji, Xiao Li ^a   Wang, Liuhong ^a   Li, Ping ^b   Ren, Yue Zhong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INSULIN GLARGINE; LIRAGLUTIDE; ANTIDIABETIC AGENT;

DISEASE ASSOCIATION; DRUG EFFECT; FATTY LIVER; HUMAN; INSULIN TREATMENT; LIPID LIVER LEVEL; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NOTE; NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEATOSIS; TREATMENT DURATION; WEIGHT REDUCTION; ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN GLARGINE; LIRAGLUTIDE; LIVER; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84956577560     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0887     Document Type: Note

References (5)

1. Tang A, Rabasa-Lhoret R, Castel H, et al. Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 2015;38:1339-1346.
2. Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, Linn T. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypo glycaemic agents (APOLLO): an open randomised controlled trial. Lancet 2008;371: 1073-1084.
3. Astrup A, Carraro R, Finer N, et al.; NN8022-1807 Investigators. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) 2012;36: 843-854.
4. Eguchi Y, Kitajima Y, Hyogo H, et al.; Japan Study Group for NAFLD (JSG-NAFLD). Pilot study of liraglutide effects in non-alcoholic steato hepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). Hepatol Res 2015;45:269-278.
5. Permutt Z, Le T-A, Peterson MR, et al. Correlation betweenliverhistology andnovel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease -MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22-29.